FLEETCOR TechnologiesNYSE: FLT

MADRID and CAMBRIDGE, Mass., June 14, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, today presents preliminary data from its ongoing Phase Ib FRIDA study investigating iadademstat in combination with gilteritinib in relapsed/refractory acute myeloid leukemia (AML) patients harboring a FMS-like tyrosine kinase mutation (FLT3 mut+) at the European Hematology Association (EHA) 2024 congress, being held in Madrid (Spain) on June 13–16. Dr. Amir Fathi, from the Massachusetts General Hospital and Principal Investigator of the study, will present a poster communication entitled “Preliminary results of the FRIDA study: iadademstat and gilteritinib in FLT3-mutated R/R AML”.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

FLEETCOR is an overlooked quality company that is currently undervalued. We have used three different valuation methods, and FLT appears undervalued in all three. Despite its high revenue and earnings growth, FLEETCOR has significantly underperformed the S&P 500 in the past five years.

ATLANTA--(BUSINESS WIRE)--FLEETCOR Technologies, Inc. (NYSE: FLT), a leading global business payments company, today announced that the Company will participate in the following investor conferences: On, Wednesday February 21, 2024, the Company will host a fireside chat at the Bank of America Financial Services Conference. The discussion will begin at 12:10 PM ET. On, Wednesday February 28, 2024, the Company will host a fireside chat at the Citi 13th Annual FinTech Conference. The discussion wi.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

FLEETCOR's (FLT) earnings and revenues grow year over year in the fourth quarter of 2023, partly due to improved segmental performance.

The headline numbers for FleetCor Technologies (FLT) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

FleetCor Technologies (FLT) came out with quarterly earnings of $4.44 per share, missing the Zacks Consensus Estimate of $4.47 per share. This compares to earnings of $4.04 per share a year ago.